Page 12:
Achieving voluntary enrolment into the trial has proven to be much more challenging than was anticipated by Neuren and the US Army. All aspects of the trial design and execution are currently under review to determine the best way forward.
I would be surprised if we managed to get results for the concussion trial in 2016.
NEU Price at posting:
11.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)